Newly Diagnosed Multiple Myeloma (NDMM) Clinical Trials in Leuven, Vlaams-Brabant

Positron Emission Tomography With Innovative Laboratory Techniques for Improved Risk and Disease Assessment in Newly Diagnosed Multiple Myeloma Patients